FDA has a new target in its continuing efforts to clean up pharmaceutical industry abuses: individual corporate officials. The most recent targets are the vice president of quality and the vice president of operations for OTC Products at McNeil Consumer Healthcare, a subsidiary of Johnson & Johnson.
FDA has approved ipilimumab (Yervoy, Bristol-Myers Squibb) to treat patients with late-stage (metastatic) melanoma, the most dangerous type of skin cancer.
FDA has approved an expanded age indication for Zoster Vaccine Live, (Zostavax, Merck) for the prevention of herpes zoster, commonly known as shingles, in adults ages 50 years and older.
SmartTots, a partnership between the International Anesthesia Research Society and FDA, is gathering more research on safe anesthesia for children under 4 years old.
The American College of Emergency Physicians and the American Association of Poison Control Centers are raising awareness about the dangers of drug poisoning as part of Poison Prevention Week, which is taking place March 20 to 26.
In this section we showcase products and product news that ran up against space limitations or fell outside the parameters of recently featured categories in the print edition. Look for more OTC Product News in upcoming issues of the Drug Topics e-newsletter.
Many patients, especially those with limited literacy, do not consolidate prescription medication regimens efficiently, which could lead to nonadherence, reported a recent study in the Archives of Internal Medicine.
A substantial portion of antiretroviral-naive patients are infected with transmitted drug-resistant HIV with 1 or more drug-resistant mutations, and they are much more likely to experience treatment failure, according to a European multicohort study published in The Lancet Infectious Disease.
"This month, the Skin Cancer Foundation?s annual Road to Healthy Skin Tour will begin a journey that will take it to 80 malls, universities, and other locations. "
The willingness of the elderly to take medication for primary cardiovascular disease prevention is relatively insensitive to its benefit but highly sensitive to its adverse effects, according to a recent study in the Archives of Internal Medicine.
Patients with psoriatic arthritis undergoing their first treatment with tumor necrosis factor-? inhibitor showed a high adherence to therapy and a good response, according to a recent Danish study in Arthritis & Rheumatism.
GlaxoSmithKline is forming a Community Pharmacy Team to help pharmacists communicate with their patients about chronic diseases and medication adherence.
Community pharmacies can partner with local law enforcement if they want to get involved in the second National Prescription Drug Take-Back Day, which will take place on April 30.
McNeil-PPC must cease manufacturing and distributing and destroy all drugs under its control that were recalled from the Fort Washington, Pa.; Las Piedras, Puerto Rico; and Lancaster, Pa., facilities since December 2009, according to a consent decree from the Department of Justice.
The U.S. House of Representatives requested in a letter to CMS that the agency consider the delay of a provision in a recently proposed rule requiring certain prescriptions to be dispensed in 7 days or less increments.
Late last week, King Pharmaceuticals, a subsidiary of Pfizer, voluntarily recalled Embeda (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules, a schedule II controlled substance, from all U.S. wholesalers and retailers.
Last week, King Pharmaceuticals, a subsidiary of Pfizer, voluntarily recalled Embeda (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules, a schedule II controlled substance, from all U.S. wholesalers and retailers.
The anticancer drug bevacizumab could help prevent babies with retinopathy of prematurity from becoming blind, reports a new study from the University of Texas Health Science Center at Houston Medical School.
New data suggest that certain prescription drug products are associated with aggression and violence toward others.
For patients seeking new ways to keep their breath fresher and their pearly whites whiter, today's manufacturers continue to develop and rebrand products to better address both the health and beauty aspects of oral care.
The U.S. Senate last month voted to repeal a 1099 tax-filing requirement that would have been time-consuming for retail pharmacists.
Drug-seekers will go to sometimes ludicrous lengths to get what they want. For the addict's equivalent of "The dog ate my homework," read on.
The California Pharmacists Association has launched what may be the nation's first employee pharmacist ombudsman program sponsored by a state association.
Patents on many small-molecule drugs, which make up some of the most popular prescription medications in the world, are set to expire during the next several years, an occurrence that is expected to cause an unprecedented shift of billions of dollars in sales to generics in the United States and other markets.
Very few state laws require a pharmacy to use a drug container that meets minimum quality-control standards. Legal metrics are needed to guard against possible patient harm resulting from an adulterated drug product caused by a "bad" container.
Technology giant Intel recently opened a health and wellness center for employees at its Jones Farm Campus in Hillsboro, Ore., that will replace many tedious trips to the doctor's office with services provided on site.
The selection of an incorrect prescriber during the prescription order entry process may have consequences long after the prescription is filled.
The skepticism of modern medicine toward the placebo effect has kept a study proving its validity hidden in the shadows of medical research instead of giving it the attention it deserves.
New guidelines in a 2010 report issued by the Centers for Disease Control and Prevention for the treatment of sexually transmitted diseases contain major updates to its 2006 report that could prove significant for the nation's pharmacies.
Recent data suggest that thrombopoietin receptor agonists are safe and effective for the treatment of chronic immune thrombocytopenic purpura, or ITP, over at least 6 years.